Form: 3

Initial statement of beneficial ownership of securities

March 3, 2010

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Darkin Donald
(Last) (First) (Middle)
9001 SPECTRUM CENTER BLVD
(Street)
SAN DIEGO CA 92123
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/01/2010 		3. Issuer Name and Ticker or Trading Symbol
RESMED INC [ RMD ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Sr. Vice President
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
ResMed NQ Stock Options 09/01/2007(1) 09/01/2016 ResMed Common Stock 10,000 40.68 D
ResMed NQ Stock Options 11/10/2007(1) 11/10/2013 ResMed Common Stock 25,000 46.19 D
ResMed NQ Stock Options 08/01/2008(1) 08/01/2014 ResMed Common Stock 25,000 43.42 D
ResMed NQ Stock Options 11/07/2008(1) 11/07/2014 ResMed Common Stock 4,000 42.05 D
ResMed NQ Stock Options 10/01/2009(1) 10/01/2015 ResMed Common Stock 10,000 43.35 D
ResMed NQ Stock Options 11/20/2009(1) 11/20/2015 ResMed Common Stock 45,000 31.04 D
Explanation of Responses:
1. Options vest 1/4 annually on the anniversary of the grant. Represents date options first became exercisable.
Remarks:
Donald Darkin, Sr. Vice President, Interfaces Strategic Business Unit 03/03/2010
** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.